The pathogenetic trigger of bronchial asthma is airway hypersensitivity.
Beclomethasone dipropionate (BDP), an adrenal cortical steroid preparation for inhalation, has been reported to suppress airway hypersensitivity. This study was designed to investigate the mechanism of this suppression of airway hypersensitivity in guinea pigs. Histamine levels in plasma and BALF significance (P <0.05) decreased after 7 days treatment at 40 puffs/day. BDP seemed to inhibit airway hypersensitivity dependent upon and the number of days of inhalation as a result of the suppression of the mast cell-histamine chain. In addition, the drug tended to suppress capsaicin-stimulated airway hypersensitivity.
The above results suggested that BDP suppresses airway hypersensitivity mediated by neuropeptides, especially by substance P. Dis., 137 : 337-340 ,1988 .
